{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:12:42Z","timestamp":1788635562095,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"DOI":"10.1007\/s00414-026-03993-w","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:01:25Z","timestamp":1788577285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-defenestration associated with 3-MeO-PCE ingestion"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-3074","authenticated-orcid":false,"given":"Adeline","family":"Knapp-Gisclon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bellouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Oliero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Rambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"3993_CR1","unstructured":"UNODC Early Warning Advisory (EWA) on New Psychoactive Substances (NPS) [Internet]. [cit\u00e9 14 juill 2026]. Disponible sur: https:\/\/www.unodc.org\/LSS\/Home\/NPS"},{"issue":"3","key":"3993_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jat\/bkae098","volume":"49","author":"AJ Krotulski","year":"2025","unstructured":"Krotulski AJ, Mata DC, Smith CR, Palmquist-Orlando KB, Modell C, Vikingsson S et al (2025) Advances in analytical methodologies for detecting novel psychoactive substances: a review. J Anal Toxicol 49(3):152\u201369. https:\/\/doi.org\/10.1093\/jat\/bkae098","journal-title":"J Anal Toxicol"},{"key":"3993_CR3","unstructured":"New psychoactive substances \u2013 the current situation in Europe (2026) | The European Union Drugs Agency (EUDA) [Internet]. [cit\u00e9 7 juill 2026]. Disponible sur: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2026\/new-psychoactive-substances_en"},{"issue":"2","key":"3993_CR4","first-page":"154","volume":"47","author":"E Lear","year":"1968","unstructured":"Lear E (1968) INTRAVENOUS ANESTHESIA \u2026 a survey of newer agents. Anesth Analg avr 47(2):154\u2013159","journal-title":"Anesth Analg avr"},{"issue":"7\u20138","key":"3993_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6(7\u20138):614\u2013632. https:\/\/doi.org\/10.1002\/dta.1620","journal-title":"Drug Test Anal"},{"issue":"2","key":"3993_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1021\/jm00326a019","volume":"8","author":"VH Maddox","year":"1965","unstructured":"Maddox VH, Godefroi EF, Parcell RF (1965) The synthesis of phencyclidine and other 1-arylcyclohexylamines. J Med Chem 8(2):230\u20135. https:\/\/doi.org\/10.1021\/jm00326a019","journal-title":"J Med Chem"},{"key":"3993_CR7","unstructured":"Arr\u00eat\u00e9 du 22 f\u00e9vrier 1990 fixant la liste des substances class\u00e9es comme stup\u00e9fiants - L\u00e9gifrance [Internet]. [cit\u00e9 14 juill 2026]. Disponible sur: https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000000533085"},{"key":"3993_CR8","doi-asserted-by":"publisher","unstructured":"UNODC Final act of the United Nations conference for the adoption of a protocol on psychotropic substances. In: The International Drug Control Conventions [Internet]. United Nations Office on Drugs and Crime; 2013 [cit\u00e9 14 juill 2026]. pp. 71\u20135. Disponible sur: https:\/\/www.un-ilibrary.org\/content\/books\/9789210555845s003-c001https:\/\/doi.org\/10.18356\/814e78a6-en","DOI":"10.18356\/814e78a6-en"},{"key":"3993_CR9","unstructured":"United Nations (1961) Single convention on narcotics drugs, 1961"},{"key":"3993_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/164_2018_124","volume":"252","author":"J Wallach","year":"2018","unstructured":"Wallach J, Brandt SD (2018) Phencyclidine-Based New Psychoactive Substances. Handb Exp Pharmacol 252:261\u2013303 doi:10.1007\/164_2018_124 PubMed PMID: 30105474","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"3993_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059334","volume":"8","author":"BL Roth","year":"2013","unstructured":"Roth BL, Gibbons S, Arunotayanun W, Huang XP, Setola V, Treble R et al (2013) The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One 8(3):e59334. https:\/\/doi.org\/10.1371\/journal.pone.0059334","journal-title":"PLoS One"},{"issue":"1","key":"3993_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/jpet.123.001942","volume":"390","author":"HE Shaw","year":"2024","unstructured":"Shaw HE, Patel DR, Gannon BM, Fitzgerald LR, Carbonaro TM, Johnson CR et al (2024) Phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel arylcyclohexylamine drugs of abuse in rodents. J Pharmacol Exp Ther 390(1):14\u201328. https:\/\/doi.org\/10.1124\/jpet.123.001942","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3993_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00204-025-04242-6","volume":"100","author":"M Noga","year":"2026","unstructured":"Noga M, Jurowski K (2026) Qualitative and quantitative in silico toxicity profiling of \u201cangel dust\u201d: phencyclidine (PCP) analogues as new psychoactive substances (3-HO-PCP, 3-MeO-PCP, 4-MeO-PCP, 3-HO-PCE, 3-MeO-PCE, 4-MeO-PCE). Arch Toxicol 100(3):1049\u201379. https:\/\/doi.org\/10.1007\/s00204-025-04242-6","journal-title":"Arch Toxicol"},{"key":"3993_CR14","unstructured":"https:\/\/psychonautwiki.org \/ [Internet]. [cit\u00e9 31 oct 2025]. 3-MeO-PCE. Disponible sur: https:\/\/psychonautwiki.org\/wiki\/3-MeO-PCE"},{"key":"3993_CR15","unstructured":"KnowDrugs 3-MeO-PCE [Internet]. [cit\u00e9 31 oct 2025]. Disponible sur: https:\/\/knowdrugs.app\/substances\/3-meo-pce"},{"issue":"1","key":"3993_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/dta.3488","volume":"16","author":"L Xu","year":"2024","unstructured":"Xu L, Liu X, Song Z, Xiang P, Hang T, Yan H (2024) In vitro and in vivo metabolism of 3-methoxyeticyclidine in human liver microsomes, a zebrafish model, and two human urine samples based on liquid chromatography-high-resolution mass spectrometry. Drug Test Anal 16(1):30\u20137. https:\/\/doi.org\/10.1002\/dta.3488","journal-title":"Drug Test Anal"},{"issue":"5","key":"3993_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/dta.2535","volume":"11","author":"N Fabresse","year":"2019","unstructured":"Fabresse N, Larabi IA, Stratton T, Mistrik R, Pfau G, Lorin de la Grandmaison G et al (2019) Development of a sensitive untargeted liquid chromatography-high resolution mass spectrometry screening devoted to hair analysis through a shared MS2 spectra database: a step toward early detection of new psychoactive substances. Drug Test Anal 11(5):697\u2013708. https:\/\/doi.org\/10.1002\/dta.2535","journal-title":"Drug Test Anal"},{"issue":"3\/suppl\u00e9ment 1","key":"3993_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/ata\/2005040","volume":"17","author":"B Dingeon","year":"2005","unstructured":"Dingeon B, Dreyfuss MF, Gaillard Y, Le Bouil A, Lhermitte M, Mazzega S et al (2005) Aide \u00e0 la validation des m\u00e9thodes en Toxicologie et Suivi Th\u00e9rapeutique Pharmacologique. Ann Toxicol Anal 17(3\/suppl\u00e9ment 1):1\u201320. https:\/\/doi.org\/10.1051\/ata\/2005040","journal-title":"Ann Toxicol Anal"},{"issue":"8","key":"3993_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/mi15080984","volume":"15","author":"R Pelixo","year":"2024","unstructured":"Pelixo R, Barroso M, Gallardo E, Rosado T (2024) Determination of arylcyclohexylamines in biological specimens: sensors and sample pre-treatment approaches. Micromachines (Basel) 15(8):984. https:\/\/doi.org\/10.3390\/mi15080984","journal-title":"Micromachines (Basel)"},{"issue":"16","key":"3993_CR20","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.1021\/acs.analchem.5c08225","volume":"98","author":"L Noreng","year":"2026","unstructured":"Noreng L, \u00d8iestad \u00c5ML, Hansen FA, R\u00f8berg-Larsen H, Wilson SR, \u00d8iestad EL (2026) Toward sustainable clinical analysis: benchmarking plastic use in LC\u2013MS sample preparation \u2013 exemplified by ketamine analogues in whole blood. Anal Chem 98(16):11899\u2013909. https:\/\/doi.org\/10.1021\/acs.analchem.5c08225","journal-title":"Anal Chem"},{"issue":"5","key":"3993_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jat\/bkt023","volume":"37","author":"G De Paoli","year":"2013","unstructured":"De Paoli G, Brandt SD, Wallach J, Archer RP, Pounder DJ (2013) From the street to the laboratory: analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices. J Anal Toxicol 37(5):277\u201383. https:\/\/doi.org\/10.1093\/jat\/bkt023","journal-title":"J Anal Toxicol"},{"issue":"5","key":"3993_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/jat\/bky109","volume":"43","author":"LA Nisbet","year":"2019","unstructured":"Nisbet LA, Wylie FM, Logan BK, Scott KS (2019) Gas chromatography-mass spectrometry method for the quantitative identification of 23 new psychoactive substances in blood and urine. J Anal Toxicol 43(5):346\u201352. https:\/\/doi.org\/10.1093\/jat\/bky109","journal-title":"J Anal Toxicol"},{"key":"3993_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2025.124464","volume":"1252","author":"Z Song","year":"2025","unstructured":"Song Z, Guo Z, Tang Y, Zhang M, Xiang P, Liu W et al (2025) Qualitative confirmation of 30 phencyclidine analogs in human blood and urine using GC-HRMS and a self-built library search. J Chromatogr B 1252:124464. https:\/\/doi.org\/10.1016\/j.jchromb.2025.124464","journal-title":"J Chromatogr B"},{"issue":"5","key":"3993_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0004563219858125","volume":"56","author":"JM Skaugen","year":"2019","unstructured":"Skaugen JM, Scoccimarro A, Pizon AF, Rymer JA, Giannoutsos S, Ekins S et al (2019) Novel ketamine analogues cause a false positive phencyclidine immunoassay. Ann Clin Biochem 56(5):598\u2013607. https:\/\/doi.org\/10.1177\/0004563219858125","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"3993_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/dta.1861","volume":"8","author":"J Wallach","year":"2016","unstructured":"Wallach J, Colestock T, Cicali B, Elliott SP, Kavanagh PV, Adejare A et al (2016) Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines. Drug Test Anal 8(8):801\u2013815. https:\/\/doi.org\/10.1002\/dta.1861","journal-title":"Drug Test Anal"},{"issue":"6","key":"3993_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.therap.2022.10.051","volume":"77","author":"J Dubois","year":"2022","unstructured":"Dubois J, Eiden C, Baudriller A, Mathieu O, Peyriere H, Cazaubon Y (2022) Intoxication grave induite par une nouvelle substance psychoactive \u00e9mergente\u202f: 3-MeO-PCE. Therapie 77(6):780\u20131. https:\/\/doi.org\/10.1016\/j.therap.2022.10.051","journal-title":"Therapie"},{"issue":"C","key":"3993_CR27","first-page":"36","volume":"56","author":"SS Stoykova","year":"2024","unstructured":"Stoykova SS, Angelov JS, Atanasov VN (2024) An application of general unknown toxicological screening in emergency medicine of new psychoactive drugs poisoning \u2013 a case report. Bulg Chem Commun 56(C):36\u201341","journal-title":"Bulg Chem Commun"},{"key":"3993_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110852","volume":"324","author":"T Gicquel","year":"2021","unstructured":"Gicquel T, Richeval C, Mesli V, Gish A, Hakim F, Pelletier R et al (2021) Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE). Forensic Sci Int 324:110852. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110852","journal-title":"Forensic Sci Int"},{"issue":"3","key":"3993_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.drugalcdep.2008.01.024","volume":"95","author":"L Muetzelfeldt","year":"2008","unstructured":"Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJA, Curran HV (2008) Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 95(3):219\u201329. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.01.024","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"3993_CR30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3109\/15563650.2015.1079325","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Beck O, Helander A (2015) Phencyclidine analog use in Sweden\u2013intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clin Toxicol (Phila) 53(9):856\u201364. https:\/\/doi.org\/10.3109\/15563650.2015.1079325","journal-title":"Clin Toxicol (Phila)"},{"issue":"52","key":"3993_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018295","volume":"98","author":"A Berar","year":"2019","unstructured":"Berar A, Allain JS, Allard S, Lefevre C, Baert A, Morel I et al (2019) Intoxication with 3-MeO-PCP alone: a case report and literature review. Medicine (Baltimore) 98(52):e18295. https:\/\/doi.org\/10.1097\/MD.0000000000018295","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"3993_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040452","volume":"17","author":"M Pepe","year":"2024","unstructured":"Pepe M, Di Nicola M, Cocciolillo F, Chiappini S, Martinotti G, Calcagni ML et al (2024) 3-Methoxy-phencyclidine induced psychotic disorder: a literature review and an 18F-FDG PET\/CT case report. Pharmaceuticals (Basel) 17(4):452. https:\/\/doi.org\/10.3390\/ph17040452","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"3993_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/02791072.2017.1333660","volume":"49","author":"S Thornton","year":"2017","unstructured":"Thornton S, Lisbon D, Lin T, Gerona R (2017) Beyond ketamine and phencyclidine: analytically confirmed use of multiple novel arylcyclohexylamines. J Psychoactive Drugs 49(4):289\u201393. https:\/\/doi.org\/10.1080\/02791072.2017.1333660","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"3993_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.annemergmed.2011.11.018","volume":"60","author":"KE Hofer","year":"2012","unstructured":"Hofer KE, Grager B, M\u00fcller DM, Rauber-L\u00fcthy C, Kupferschmidt H, Rentsch KM et al (2012) Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med 60(1):97\u20139. https:\/\/doi.org\/10.1016\/j.annemergmed.2011.11.018","journal-title":"Ann Emerg Med"},{"issue":"5","key":"3993_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00228-011-1199-9","volume":"68","author":"DM Wood","year":"2012","unstructured":"Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI (2012) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 68(5):853\u20136. https:\/\/doi.org\/10.1007\/s00228-011-1199-9","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3993_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.toxlet.2014.08.011","volume":"230","author":"JB Zawilska","year":"2014","unstructured":"Zawilska JB (2014) Methoxetamine \u2013 a novel recreational drug with potent hallucinogenic properties. Toxicol Lett 230(3):402\u20137. https:\/\/doi.org\/10.1016\/j.toxlet.2014.08.011","journal-title":"Toxicol Lett"},{"issue":"3","key":"3993_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12630-019-01548-9","volume":"67","author":"YK Jean","year":"2020","unstructured":"Jean YK, Gitlin MC, Reynolds J, Candiotti KA (2020) Tramadol-associated hallucinations: a systematic review and narrative synthesis of their pathophysiology, diagnosis, and treatment. Can J Anesth Can Anesth 67(3):360\u20138. https:\/\/doi.org\/10.1007\/s12630-019-01548-9","journal-title":"Can J Anesth Can Anesth"},{"issue":"5","key":"3993_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000528573","volume":"56","author":"VY Skryabin","year":"2023","unstructured":"Skryabin VY, Martinotti G, Franck J, Zastrozhin MS (2023) Acute alcoholic hallucinosis: a review. Psychopathology 56(5):383\u201390. https:\/\/doi.org\/10.1159\/000528573","journal-title":"Psychopathology"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-026-03993-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00414-026-03993-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-026-03993-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:02:57Z","timestamp":1788634977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00414-026-03993-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":38,"alternative-id":["3993"],"URL":"https:\/\/doi.org\/10.1007\/s00414-026-03993-w","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}